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ABSTRACT 
SURVEILLANCE AFFECTING INFECTION CONTROL IN A VETERINARY 
TEACHING HOSPITAL 
Healthcare-associated infections (HCAI) are poorly understood in veterinary 
medicine.  Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is an 
increasingly reported pathogen of dogs.  Consequently, there are increasing concerns 
regarding treatment difficulties and propagation of antibiotic resistance.  The first study 
seeks to estimate the burden of MRSP carriage among dogs presenting to the Colorado 
State University Veterinary Teaching Hospital (CSU-VTH). 
This study enrolled 243 canine patients across 3 different hospital services upon 
admission to the VTH and 155 canine patients across 3 different hospital services that 
received paired samples at two different time points.  The 3 hospital services were 
Community Practice (healthy patients), Dermatology (patients with skin disease) and 
Surgical Oncology (patients with a higher risk of acquiring an infection during visit). 
The estimated prevalence of MRSP carriage at enrollment and follow-up was 4%.  
For enrollment samples, no patients enrolled through Community Practice carried 
MRSP, while 8% of Dermatology patients and 3% of Surgical Oncology patients were 
MRSP carriers.  For paired samples, carriage persistence was only seen for patients 
enrolled through Dermatology.  
Results of this study showed that the prevalence of MRSP carriers among dogs 
presenting to the CSU-VTH falls within ranges previously published.  MRSP 
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colonization was seen most commonly among dogs with skin disease and least 
commonly among healthy dogs.  
The second study focuses on surveillance for HCAIs via patient temperatures stored 
in the electronic medical record (EMR) system of a VTH.  Little work has been done in 
veterinary medicine on surveillance of HCAIs in a VTH.  The EMR system contains 
patient temperature data for each visit.  This study explores the association between 
fevers after admission and known risk factors for HCAIs (e.g. duration of stay in the 
hospital, critical care involvement). 
This study included all medical records corresponding to canine visits from the 
period of January 1, 2012 to June 30, 2015.  After selecting for visits of ≥ 1 night and 
removing missing data, 6,254 unique canine visits remained.  Visits were classified into 
type of case (Medicine, Surgery, Oncology, Other) and whether criticial care (ECC) was 
involved).  Length of stay was determined based on admission and discharge date.  A 
visit that produced a fever after admission was a visit where the animal had a normal 
rectal temperature (≤102.5°F) upon admission and subsequently produced a fever 
(>102.5°F) after admission.  The cumulative incidence of fevers after admission was 
calculated.  Odds ratios (OR) between fevers after admission and case type and ECC 
involvement and duration of stay in the hospital were calculated via multivariable logistic 
regression. 
The estimated cumulative incidence of fevers after admission was 9%.  Results of 
multivariable regression showed that a negative association existed between Medicine-
type cases, Oncology-type cases and long duration of hospitalization (>2 days).   
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This study shows that fevers after admission are associated with known risk factors 
for HCAIs and may be useful in a syndromic approach to HCAI surveillance.  This study 
did not explore the association between HCAI and fevers after admission. 
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1 Review of Literature 
1.1 Staphylococcus pseudintermedius and methicillin-resistance 
1.1.1 Overview 
Bacteria of the genus Staphylococcus are commensals of the skin and mucous 
membranes of both humans and animals.    Under favorable conditions, some 
Staphylococcus spp. may become pathogenic (Morris, Boston, O’Shea, & Rankin, 
2010).  Staphylococcus spp. exhibit a species predilection, with Staphylococcus aureus 
the main staphylococcal pathogen (Chiller, Selkin, & Murakawa, 2001; Fredricks, 2001) 
of humans and Staphylococcus pseudintermedius the main commensal/pathogen of 
dogs (Bannoehr & Guardabassi, 2012).  In dogs, Staphylococcus spp. have been 
known to cause infections of the skin, ears, surgical sites/wounds and urinary tract (van 
Duijkeren et al., 2011; Weese & van Duijkeren, 2010).  The most common 
staphylococcal pathogen of dogs is S. pseudintermedius, and is also a commensal of 
canine mucous membranes and skin (Bannoehr & Guardabassi, 2012; Hartmann, 
White, West, Walker, & DeBoer, 2005).  S. pseudintermedius is not a normal 
commensal of humans (Guardabassi, Loeber, & Jacobson, 2004), but has been 
reported to be able to colonize (Morris et al., 2010; Paul, Moodley, Ghibaudo, & 
Guardabassi, 2011) and cause infection in humans (Campanile et al., 2007; Somayaji, 
Priyantha, Rubin, & Church, 2016; Talan, Goldstein, Staatz, & Overturf, 1989). 
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1.1.2 History of S. pseudintermedius 
Historically, routine diagnostic bacteriology for Staphylococcus spp. hinged upon 
the coagulase test, classifying all coagulase-positive Staphylococcus spp. (CPS) as S. 
aureus (Devriese et al., 2005).  Coagulase-negative Staphylococcus spp. (CNS) were 
considered non-pathogenic and ignored as potential causes of disease.  In 1976, Hajek, 
based on isolates from pigeons, dogs, minks and horses, reported the discovery of a 
new species within the genus Staphylococcus, noting heterogeneities within the S. 
aureus group.  Hajek called this new species S. intermedius with microbiological 
features that, up until 1976, was considered to be characteristic of S. aureus (Hajek, 
1976).  For 30 years, S. intermedius was considered a common cause of skin and soft 
tissue infections in dogs (Allaker, Lloyd, & Bailey, 1992; Allaker, Lloyd, & Simpson, 
1992; Cox et al., 1988; Devriese & De Pelsmaecker, 1987; Medleau, Long, Brown, & 
Miller, 1986; Werckenthin, Cardoso, Martel, & Schwarz, 2001). 
Since Hajek’s discovery, other microbiological features were discovered 
providing further differentiation of the CPS spp. (Devriese et al., 2005).  Staphylococcus 
hyicus was discovered in 1978 (Devriese et al., 1978). S. delphini was discovered in 
1988 (Varaldo, Kilpper-Balz, Biavasco, Satta, & Schleifer, 1988), S. schleiferi subsp. 
coagulans was discovered in 1990 (Igimi, Takahashi, & Mitsuoka, 1990) and S. lutrae 
was discovered in 1997 (Foster, Ross, Hutson, & Collins, 1997).  S. pseudintermedius 
was discovered in 2005 (Devriese et al., 2005) based on molecular characterization.  
Biochemical identification of some staphylococcal species, particularly coagulase-
negative Staphylococci with routine testing is a challenge requiring automated systems 
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involving performance of extensive phenotypic testing and molecular identification 
(Devriese et al., 2005). 
S. delphini isolates and S. pseudintermedius strains have the same phenotypic
characteristics. S. intermedius (Devriese et al., 2005; Varaldo et al., 1988) came to be 
known as the S. pseudintermedius group (SIG).  Molecular methods are required to 
differentiate S. delphini, S. intermedius and S. pseudintermedius (Sasaki et al., 2007a).  
Thus, prior to the description of S. delphini and S. pseudintermedius, routine diagnostic 
bacteriologic isolates identified as S. intermedius could have been any member of the 
SIG.  Species from which the bacteria was isolated provided valuable information as to 
which member of the SIG the isolate truly belonged, e.g. isolates from a dolphin would 
most likely be S. delphini. In 2007, it was shown that the majority of S. intermedius 
isolated from dogs were S. pseudintermedius, leading to the convention in 
nomenclature that all SIG isolates identified via routine methods from dogs are identified 
as S. pseudintermedius (Devriese, Hermans, Baele, & Haesebrouck, 2009; Sasaki et 
al., 2007b).  This allows for the presumptive identification of S. pseudintermedius 
without further molecular testing to differentiate it from the other SIG members 
(Devriese et al., 2009). 	
1.1.3 S. pseudintermedius as a commensal 
S. pseudintermedius is a commensal of healthy canine skin and mucous
membranes (Bannoehr & Guardabassi, 2012).  It has been isolated from various 
anatomical sites of healthy dogs, including the nasal vestibulum, external auditory 
canal, anal mucosa and on the skin surface and hair coat (Griffeth, Morris, Abraham, 
Shofer, & Rankin, 2008).  Genetic diversity of S. pseudintermedius colonizing healthy 
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dogs is often high (Paul et al., 2011).  The most common colonization sites for MRSP in 
dogs appear to be the pharynx/oral cavity, rectum/perineum (Paul et al., 2011; Rubin & 
Chirino-Trejo, 2011) and nasal vestibulum (Devriese & De Pelsmaecker, 1987) 
1.1.4 S. pseudintermedius as a pathogen 
S. pseudintermedius causes opportunistic disease when the physical or
immunological barriers to infection are lowered due to alterations in the skin barrier (due 
to predisposing factors such as atopic dermatitis), medical and surgical procedures 
and/or immunosuppressive disorders (Bannoehr & Guardabassi, 2012).  S. 
pseudintermedius is involved in canine pyoderma, otitis, wound and surgical infections 
and abscesses (van Duijkeren et al., 2011; Weese & van Duijkeren, 2010).  Since S. 
pseudintermedius is a normal commensal of canine skin and mucous membrane flora, 
infections by S. pseudintermedius are opportunistic and infection itself not transmissible 
by direct contact between healthy and diseased dogs (Bannoehr & Guardabassi, 2012).  
Pathogenicity of S. pseudintermedius does not appear to be related to strain. 
Non-diseased dogs seem to carry a genetically diverse population of S. 
pseudintermedius in various anatomical sites (Bannoehr & Guardabassi, 2012; 
Fazakerley, Williams, Carter, McEwan, & Nuttall, 2010; Pinchbeck et al., 2006).  
Genetic diversity appears to decrease in dogs with superficial bacterial folliculitis 
(Pinchbeck et al., 2006) and atopic dermatitis (Fazakerley et al., 2010).   
In humans, colonization by S. aureus is a risk factor for subsequent infection by 
S. aureus.  However, in dogs, the relationship of colonization and S. pseudintermedius
infection is unclear.  Non-methicillin resistant S. pseudintermedius strains isolated at the 
site of skin infection were found via pulsed-field gel electrophoresis to be identical to 
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those found at colonization site(s) on the same patient (Fazakerley et al., 2010; 
Pinchbeck et al., 2006; A. Sasaki et al., 2005).   
1.1.5 Methicillin-resistant S. pseudintermedius 
Prior to the emergence of methicillin-resistance, S. pseudintermedius was 
susceptible to beta-lactam antibiotics (Weese & van Duijkeren, 2010).  However, since 
2006, reports of methicillin resistance among S. pseudintermedius have been 
increasing (van Duijkeren et al., 2011).  Methicillin-resistance is conferred upon S. 
pseudintermedius, as it is with S. aureus via acquisition of the mecA gene.  This gene 
encodes an altered penicillin-binding-protein-2a (PBP2a) that is present in the cell wall.  
PBP2a confers in vivo resistance to all beta-lactam antibiotics because this class cannot 
bind to the bacterial call wall to exert its bacteriocidal effects (Berger-Bächi & Rohrer, 
2002; Hartman & Tomasz, 1984; Kwon et al., 2005; van Duijkeren, Box, Heck, Wannet, 
& Fluit, 2004).  Reports from Europe and North America show that MRSP isolates are 
commonly resistant to various classes of antimicrobials (Gold, Cohen, & Lawhon, 2014; 
Nienhoff et al., 2011), including fluoroquinolones, lincosamides, macrolides, 
aminoglycosides, sulfonamides and chloramphenicols (Gold et al., 2014; Nienhoff et al., 
2011).  Therapeutic options may be limited, however, effective topical therapies and/or 
systemic therapies are often still available. 
Dogs may be contaminated, colonized or infected with MRSP.  When a dog is 
contaminated with MRSP, the bacteria have not invaded tissue,are not replicating and 
can be easily washed off.  Often, only one culture of the dog is positive, while 
subsequent cultures are negative (van Duijkeren et al., 2011).  When a dog is 
persistently colonized with MRSP, the bacteria have become a part of the microbial flora 
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of the dog.  Dogs that are colonized with MRSP are called “carriers” (van Duijkeren et 
al., 2011).  As such, colonization and carriage are used interchangeably.  In colonized 
individuals, bacteria are not prompting an immune response, and not necessarily 
causing observable clinical signs.or immune reactions (van Duijkeren et al., 2011).  
Distinguishing between MRSP contamination and colonization of a patient requires 
multiple samples to be taken from a patient.  Colonization sites include groin, mouth, 
anus, head and mucosa (Griffeth et al., 2008), with the anal region and nasal mucosa 
being the most frequently colonized sites (Fazakerley et al., 2009; Weese & van 
Duijkeren, 2010).  The anal region seems to be the most heavily colonized (Devriese & 
De Pelsmaecker, 1987). When a dog is infected with MRSP, the bacteria have invaded 
a body site, is multiplying and causing observable clinical signs (van Duijkeren et al., 
2011).  
1.1.6 Epidemiology of MRSP 
Frequency of isolation of MRSP from dogs with active skin infections in the 
United States has increased dramatically in the last decade (Frank, Kania, Kirzeder, 
Eberlein, & Bemis, 2009; Jones, Kania, Rohrbach, Frank, & Bemis, 2007; Kania et al., 
2004), with prevalence at 0% (0/210) prior to 1986 (Medleau et al., 1986), 3.5% (2/57) 
from 1999 to 2001 (Kania et al., 2004) and 7% (4/59) from 2005 to 2006 (Griffeth et al., 
2008).  Prevalence of methicillin-resistance among S. pseudintermedius isolates from 
clinical samples submitted to a veterinary diagnostic laboratory increased from 5% in 
2001 to 30% in 2007 (Bemis, Jones, Frank, & Kania, 2009). Prevalence of MRSP 
colonization in healthy dogs has been reported to range from 2% to 6% (Detwiler, 
Bloom, Petersen, & Rosser, 2013; Hanselman, Kruth, & Weese, 2008).  Reports as high 
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as 16% have been reported (Epstein, Yam, Peiris, & Epstein, 2009).  MRSP 
colonization prevalence varies with geographic region, e.g. 1.5% (3/200, Slovenia, 
2005) (Vengust, Anderson, Rousseau, & Weese, 2006), and 16.7% (6/36, Hong Kong, 
2008) (Epstein et al., 2009).  MRSP colonization prevalence in northern Colorado, 
among shelter dogs, has been estimated to be 3% (6/200, United States, 2009) 
(Gingrich, Kurt, Hyatt, Lappin, & Ruch-Gallie, 2011).  
MRSP transmission occurs via animal-to-animal contact (van Duijkeren et al., 
2011; Guardabassi, Schwarz, & Lloyd, 2004; Harvey & Noble, 1998; van Duijkeren et 
al., 2011; Zubeir et al., 2007).  Humans may also transmit MRSP from one patient to 
another (van Duijkeren et al., 2011; Guardabassi et al., 2004; van Duijkeren et al., 2011; 
Zubeir et al., 2007).  While rare, human infections with MRSP have been reported 
(Campanile et al., 2007; Gerstadt, Daly, Mitchell, Wessolossky, & Cheeseman, 1999; 
Kempker, Mangalat, Kongphet-Tran, & Eaton, 2009; Somayaji et al., 2016; Starlander, 
Börjesson, Grönlund-Andersson, Tellgren-Roth, & Melhus, 2014; Stegmann, Burnens, 
Maranta, & Perreten, 2010).  MRSP has also been isolated from household 
environments with actively infected animals (van Duijkeren et al., 2011). 
Although active MRSP infections resolve with appropriate topical and/or systemic 
therapy, MRSP may persist in colonization sites (e.g. nose, mouth, rectum, axilla or 
perineal regions) for as long as 6 months post-therapy (Laarhoven et al., 2011).  
Healthy patients presenting for wellness checks may also carry MRSP asymptomatically 
in various colonization sites (e.g. nose, rectum) (Beck, Waisglass, Dick, & Weese, 2012; 
Gingrich et al., 2011; Griffeth et al., 2008; Nienhoff et al., 2011).  Colonized patients 
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may be a source of MRSP environmental contamination increasing the risk for 
nosocominal colonization or infection of canine patients (Beck et al., 2012). 
1.1.7 Treatment and Control of MRSP 
There is no indication that MRSP is more virulent than methicillin-susceptible S. 
pseudintermedius (MSSP), though resolution may take longer with MRSP (Frank et al., 
2009).  While bacterial culture and susceptibility is always recommended (Hillier et al., 
2014) and basing treatments on culture and susceptibility results allows for prudent use 
of antimicrobials, initial treatments may begin based on clinical assessment of risk for 
resistance.  For instance, for cases of superficial bacterial folliculitis at low risk of 
resistance, it is recommended that beta-lactams or clindamycin are used if culture and 
susceptibility is not an option.  However, if resistance is suspected due to history or lack 
of response, then treatment should be based on culture and susceptibility (Frank & 
Loeffler, 2012; Hillier et al., 2014).  Situations that would warrant culture and 
susceptibility include failure to respond to appropriate antimicrobial treatment and a 
history of multidrug resistant infection in the dog or a pet from the same household as 
the dog.  Resistant infections by S. pseudintermedius should be suspected when initial 
treatments fail or in patients with prior exposure to many antimicrobial classes (Hillier et 
al., 2014).  
Anecdotal evidence exists for treatment success with chloramphenicol (Bryan et 
al., 2012).  Adverse effects include gastrointestinal upset and weight loss as well as 
hindlimb muscle weakness (Bryan et al., 2012; Frank & Loeffler, 2012).  
Chloramphenicol is an inhibitor of the cytochrome P450 3A isoenzymes leading to 
potential drug toxicity (Pai, Momary, & Rodvold, 2006).  Other adverse effects include 
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liver toxicity and bone marrow suppression (Greene, Hartmann, & Calpin, 2006).  
Routine monitoring of dogs on chloramphenicol should be performed, including blood 
screening for inappetant dogs or dogs that exhibit substantial weight loss (Frank & 
Loeffler, 2012; Greene, 2013).  Its use is limited largely by human health concerns.  
While rare, exposure to chloramphenicol may lead to aplastic anemia in humans, a 
potentially fatal condition.  Use of chloramphenicols should be accompanied by strict 
adherence to handling precautions (Greene, 2013).  
Rifampicin is an effective treatment against Staphylococcus spp. and has great 
tissue penetration (Frank, 1990).  Against MRSP strains, however, rifampicin may be 
ineffective (Kadlec, Duijkeren, Wagenaar, & Schwarz, 2011).  One adverse effect of 
rifampicin therapy is hepatotoxicity (Bajwa, Charach, & Duclos, 2013; Frank, 1990).  
Patients should be monitored for concurrent increases in hepatic enzyme activity (Bajwa 
et al., 2013; Frank & Loeffler, 2012).  Other clinical signs include thrombocytopenia, 
hemolytic anemia, anorexia, vomiting and diarrhea (Frank & Loeffler, 2012).  Body 
secretions, such as urine, feces, saliva and tears may be red-orange (Frank & Loeffler, 
2012).  Rifampicin is an inducer of cytochrome P450 3A isoenzymes which can 
potentially lead to subtherapeutic levels (Baciewicz, Self, & Bekemeyer, 1987; Pai, 
Momary, & Rodvold, 2006). 
Amikacin, historically, has not been commonly used in treating skin infections 
due to its parenteral administration, which is less acceptable to clients (Frank & Loeffler, 
2012) and potential for nephrotoxicity and ototoxicity. Usage has been increasing due to 
MRSP, however (Frank & Loeffler, 2012)..  Nephrotoxicity is the major potential adverse 
effect and (Frank & Loeffler, 2012).  Meticulous monitoring for signs of acute kidney 
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injury, e.g. renal casts, glycosuria and azotemia, is extremely important when using 
amikacin, and can often deter the use of amikacin (Noli & Morris, 2011).  Use of 
amikacin should be based on culture and susceptibility results that show no other 
antibiotics would be effective (Frank & Loeffler, 2012) and if topical therapy options are 
exhausted or impossible. 
Tetracycline resistance is common in both MSSP and MRSP (Frank & Loeffler, 
2012).  Tetracycline resistance is conferred by the tet(K) and tet(M) genes (Frank & 
Loeffler, 2012).  The tet(K) gene confers resistance to tetracycline but not doxycycline 
or minocycline (Frank & Loeffler, 2012).  The tet(M) gene confers resistance to 
tetracycline, doxycycline and minocycline (Frank & Loeffler, 2012).  Susceptibility of 
both tetracycline and minocycline should be performed.  Resistance to minocycline 
indicates the presence of the tet(M) gene, implying the organism is resistant to 
tetracycline, doxycycline and minocycline. Minocycline may be considered a  
therapeutic option if doxycycline resistance is present, as it is generally well tolerated. In 
MRSA, doxycycline resistance can be induced by pre-incubation with tetracycline or 
doxycycline (Schwartz et al., 2009; Trzcinski, Cooper, Hryniewicz, & Dowson, 2000).  It 
is not known if this is the case for MRSP (Frank & Loeffler, 2012). 
Clindamycin is considered a first-line antibiotic in treating pyoderma in dogs 
(Bloom & Rosser, 2001; Frank & Loeffler, 2012; Littlewood, Lakhani, Paterson, Wood, & 
Chanter, 1999;Scott, Beningo, Miller, & Rothstein, 1998) and is a good choice for MRSP 
that is susceptible to clindamycin due to fewer adverse effects (Frank & Loeffler, 2012).  
However, clindamycin-susceptible MRSP is uncommon, and interpretation of 
susceptibility results can be complicated by inducible clindamycin resistance (Ganiere, 
	11 
Medaille, & Mangion, 2005).  Inducible clindamycin resistance should be suspected 
when the organism is resistant to erythromycin in vitro but susceptible to clindamycin.  A 
“D-Test” (double-disc diffusion test) can be performed to determine if inducible 
clindamycin resistance is present.  The D-test tests for clindamycin-resistance among 
staphylococci by placing erythromycin discs in close proximity to a clindamycin disc.  
Clindamycin-resistance is indicated by a “D” shaped zone of inhibition around the 
clindamycin-disc. 
Fluoroquinolone-resistance among MRSP strains is common.  As such, it may be 
considered a poor treatment option for MRSP (Perreten et al., 2010).  However, in 
susceptible cases, fluoroquinolones may be preferable to rifampicin and amikacin due 
to adverse side effects given fewer adverse side effects.  Population consumption of 
fluoroquinolones are associated with isolation of MRSA in humans (Venezia, 
Domaracki, Evans, Preston, & Graffunder, 2001; Weber, Gold, Hooper, Karchmer, & 
Carmeli, 2003) and, while unproven, may be the case for MRSA infection in dogs (Frank 
& Loeffler, 2012).  It is not known if fluoroquinolones select for MRSP (Frank & Loeffler, 
2012). Due to the risks and lack of therapeutic effect against MRSP infections, it is 
recommended that antibiotics of the fluoroquinolone class be reserved for deep 
infections associated with Gram-negative organization, and not for staphylococcal 
infections (Frank & Loeffler, 2012) . 
Although, linezolid has been used successfully in the treatment of methicillin-
resistant staphylococci (Murphy, 2008), and some commercial laboratories may present 
data for linezolid and vancomycin, these drugs are considered last-resort treatments for 
human MRSA patients, and use in veterinary medicine is strongly discouraged.  No 
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reports have been published regarding the use of linezolid to treat MRSP infections in 
dogs in a clinical setting (Frank & Loeffler, 2012).  Less evidence exists for vancomycin 
in the treatment of these organisms in dogs (Frank & Loeffler, 2012).    
Topical therapy may be used as a sole therapy or in conjunction with systemic 
therapy for superficial staphylococcal pyoderma (involving the epidermis and hair 
follicle) and otitis externa in methicillin-susceptible or methicillin resistant infections 
(Frank & Loeffler, 2012; Loeffler, Cobb, & Bond, 2011; Loeffler et al., 2007). Topical 
therapy alone may not be able to resolve deep pyoderma (staphylococcal infection of 
the skin involving the dermis and/or subcutis). Shampoos that have demonstrated 
therapeutic responses in dogs with superficial bacterial folliculitis include those that 
contain chlorhexidine, benzoyl peroxide or ethyl lactate (Frank & Loeffler, 2012).  
Effective options for focal lesions include chlorhexidine spray, mupirocin ointment, 
benzoyl peroxide gel, fusidic acid or nisin (Frank & Loeffler, 2012; Werner & Russell, 
1999).  MRSP isolates appear to be largely susceptible to mupirocin and fusidic acid, 
however, resistance have been identified (Loeffler et al., 2008).  Although 
undocumented, it is possible that staphylococcal organisms may develop resistance to 
topical antimicrobials, including chlorhexidine, and fusidic acid (Frank & Loeffler, 2012).  
Prudent use of topical therapies is always advised (Frank & Loeffler, 2012) , in particular 
with mupirocin and fusidic acid, given known resistance.  However, there is less 
concern over chlorhexidine and benzoyl peroxide (Borio et al., 2015).  Decolonization of 
MRSP in dogs (as is done with MRSA in humans) is neither practiced nor generally 
recommended and is controversial due to lack of studies supporting this practice (Frank 
& Loeffler, 2012) . 
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Veterinary hospital infection control practices regarding MRSP involve hand and 
environmental hygiene.  Hand and environmental hygiene minimize the potential of 
unrecognized carriers and contaminated hands and objects (humans and animals) 
spreading the organism between patients (Frank & Loeffler, 2012).  For MRSA, 
colonization in dogs resolved spontaneously through regular kennel cleaning alone 
(Loeffler et al., 2010).  Although less is known about longitudinal carrier status in MRSP, 
this highlights the importance of environmental hygiene.  Healthy dogs in contact with 
MRSP infected pets also show higher MRSP colonization rates (36%) (van Duijkeren et 
al., 2011).  As such, isolation procedures within a veterinary setting for MRSP infected 
animals may be a necessary precaution (Frank & Loeffler, 2012).  Isolation procedures 
include the use of barrier nursing precautions (protective aprons, overshoes, gloves) 
and limiting staff contact (van Duijkeren et al., 2011). 
1.1.8 Zoonotic risk 
Human colonization and infection by MSSP and MRSP are uncommon and is 
most likely due to the host predilection of S. pseudintermedius spp. to canines (van 
Duijkeren et al., 2011).  Human cohabitation with dogs with deep pyoderma that are 
actively infected with MSSP appears to be associated with S. pseudintermedius 
colonization in humans (Guardabassi et al., 2004).  However, MSSP colonization of this 
group of humans was short-term and resolved with the resolution of purulent lesions of 
the dog (Guardabassi et al., 2004). Human colonization by MSSP may also be 
associated with members of the veterinary profession (Hanselman, Kruth, Rousseau, & 
Weese, 2009; van Duijkeren et al., 2011).  Infections with MSSP have been associated 
with dog bite wounds (Kelesidis & Tsiodras, 2010; van Duijkeren et al., 2011), 
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bacteremia (Somayaji et al., 2016; Vandenesch et al., 1995), brain abscess (Atalay, 
Ergin, Cekinmez, Caner, & Altinors, 2005), pneumonia (Gerstadt et al., 1999), ear 
infections (Kikuchi et al., 2004), varicose leg ulcers (van Duijkeren et al., 2011), surgical 
site infections and an infected implantable defibrillator (Riegel et al., 2011; van 
Duijkeren et al., 2011).  Findings for human MRSP colonization appear to be similar 
(Hanselman et al., 2009; Sasaki et al., 2007a; van Duijkeren et al., 2008) and appears 
to be associated with members living in a household with an MRSP positive dog and/or 
members of the veterinary profession (van Duijkeren et al., 2011).  While rare, MRSP in 
humans (Somayaji et al., 2016) has been associated with bacteremia in cancer patients 
(Campanile et al., 2007), pneumonia (Gerstadt et al., 1999) and post-operative sinus 
infections (Kempker et al., 2009).  A cluster of wound infections by MRSP occurring in a 
human tertiary hospital has also been reported (Starlander et al., 2014). 
1.2 Healthcare-associated infections in veterinary teaching hospitals 
1.2.1 Impact of HCAIs in human and veterinary medicine 
Much work has been performed on the impact of HCAIs in human medicine.  
Studies in human medicine would suggest that HCAIs cause a significant medical and 
financial toll among patients, the hospital and the healthcare system (Calfee, 2012).  It 
is estimated that the overall direct medical costs of HCAIs in U.S. human hospitals 
ranges from $28 billion to $45 billion per year (Calfee, 2012; Scott, 2009).  Estimates for 
cost per infection for surgical site infections range from $10,443 (2005 dollars) to 
$25,546 (2002 dollars) per infection (Scott, 2009).  Cost per infection for central line-
associated bloodstream infections ranged from $5,734 (2003 dollars) to $22,939 (2003 
dollars) per infection (Scott, 2009).  The cost for ventilator-associated pneumonias 
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ranged from $11,897 (1999 dollars) to $25,072 (2005 dollars) per infection (Scott, 
2009).  And the cost for catheter-associated urinary tract infections was estimated to be 
approximately $758 per infection (Scott, 2009).   
Based on data submitted to the National Nosocomial Infection Surveillance 
(NNIS) system of the Centers for Disease Control (CDC) in 2002, >1.7 million HCAIs 
occur in hospital patients per year (Calfee, 2012; Klevens et al., 2007).  These results 
would further suggest that approximately 5% of patients admitted to a hospital develop 
an infection during hospitalization.  In 2002, there were 98,000 deaths due to HCAI 
(Klevens et al., 2007), placing HCAI within the top ten causes of death in the United 
States (Calfee, 2012).  A study that further examined HCAI as the cause of death 
among unexpected in-hospital deaths, 31% were possibly or probably related to HCAI 
(Morgan, Lomotan, Agnes, McGrail, & Roghmann, 2010).  This suggests that many of 
these patients did, in fact, die due to HCAI instead of dying with HCAI (Carrico & 
Ramírez, 2007).  One study estimated that approximately 45% to 69% of these HCAI 
events are preventable (Umscheid et al., 2011).    
There are fewer studies regarding the health and economic impacts of HCAIs in 
veterinary hospitals.  This may be attributed to the fact that veterinary infection control is 
a relatively new discipline (Burgess & Morley, 2015). HCAI events in both small animal 
(Cherry et al., 2004; Weese & Armstrong, 2003) and large animal veterinary hospitals 
(Castor, Wooley, Shotts, Brown, & Payeur, 1989; Dallap Schaer, Aceto, & Rankin, 
2010; Goehring, Landolt, & Morley, 2010; Hartmann, Callan, McGuirk, & West, 1996; 
Konkle, Nelson, & Lunn, 1997; Madewell et al., 1995; Schott II et al., 2001; Seguin et 
al., 1999; Steneroden, Van Metre, Jackson, & Morley, 2010; Tillotson et al., 1997; Ward 
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et al., 2005; Weese et al., 2006) have been reported and have caused significant 
consequences, including longer visit durations (13 months) (Seguin et al., 1999), 
hospital closures (Goehring et al., 2010; Schott II et al., 2001; Tillotson et al., 1997; 
Weese & Armstrong, 2003) and facility renovations (Dallap Schaer et al., 2010; Tillotson 
et al., 1997) and euthanasia of patients (Dallap Schaer et al., 2010; Goehring et al., 
2010; Hartmann et al., 1996; Konkle et al., 1997; Schott II et al., 2001; Steneroden et 
al., 2010; Tillotson et al., 1997).  Multidrug resistance has been associated with the 
causative agents implicated in several veterinary HCAI outbreaks (Dallap Schaer et al., 
2010; Hartmann et al., 1996; Schott II et al., 2001; Seguin et al., 1999; Ward et al., 
2005; J. S. Weese et al., 2006).  Additionally, zoonotic infections have also been 
reported during HCAI outbreaks (Cherry et al., 2004; Konkle et al., 1997; Schott II et al., 
2001; Seguin et al., 1999; Weese et al., 2006). 
Economic impacts were only reported for two studies.  Renovations to facilities 
were reported to cost $550,000 (Tillotson et al., 1997) in one study and lost revenue 
due to hospital closure, staged reopening, decreased caseload, facility remediation and 
decontamination and hospital coverage of patient bills was estimated at $4.12 million 
(Dallap Schaer et al., 2010) for another study. The pathogen involved in both of these 
outbreaks of HCAIs was Salmonella. 
1.2.2 Syndromic surveillance for HCAI 
Syndromic surveillance can be defined as the use of health-related data, such as 
non-specific indicators of disease, that precede diagnosis to signal with sufficient 
probability the occurrence of a case or outbreak that warrants a health response 
(Dorea, Sanchez, & Revie, 2011; Henning, 2004; Ruple-Czerniak et al., 2013).  These 
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non-specific measures of disease can include clinical signs (e.g. IV catheter site 
inflammation, urinary tract inflammation, acute respiratory disorders, gastrointestinal 
disorders, surgical site inflammation and fevers of unknown origin) (Ruple-Czerniak et 
al., 2013) or other pre-diagnosis health-related measures, such as pharmacy sales, 
presenting complaint upon presentation to the hospital or laboratory test orders (Dorea 
et al., 2011).  
Several advantages exist for syndromic surveillance.  Syndromic surveillance 
makes use of pre-diagnostic data that, while less specific than a confirmatory diagnosis 
is often reported more frequently and can be utilized in a real-time analysis and 
interpretation (Dorea et al., 2011). While the data may not be representative of the 
disease burden in the entire population, the assumption is that syndromic surveillance 
data are sensitive to disease fluctuations in the population (Dorea et al., 2011; Yahav & 
Shmueli, 2007).  This may provide an early, albeit weak, signal of an HCAI event 
(Yahav & Shmueli, 2007). 
Syndromic surveillance systems can be utilized to understand risk factors for 
HCAI events across multiple hospitals.  A syndromic surveillance study to estimate 
baseline rates for HCAIs in small animal critical care units of veterinary referral hospitals 
used the following syndromes: IV catheter site inflammation, urinary tract inflammation, 
acute respiratory disorders, gastrointestinal disorders, surgical site inflammation and 
clinical or microbiological evidence of septicemia (Ruple-Czerniak et al., 2013).  Positive 
associations existed between the syndromes and increased duration in the hospital, 
undergoing surgery and placement of a urinary catheter (Ruple-Czerniak et al., 2013).  
The study also concluded that syndromic surveillance systems can be standardized 
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across multiple hospitals for effective data collection of HCAI rates and risk factors for 
occurrence (Ruple-Czerniak et al., 2013). 
1.2.3 The electronic medical record and patient rectal temperatures as a tool for 
surveillance 
The electronic medical record (EMR) is a relatively new technology in veterinary 
medicine.  There is little reported about the use of EMR systems in veterinary hospitals.  
One study performed in 1996 reported that completeness and accuracy of data entered 
were so inadequate such that the intended research on post-operative complications 
following elective surgeries using data stored in the EMR was impossible (Pollari, 
Bonnett, Allen, Bamsey, & Martin, 1996).  At the current time, several VTHs have fully 
transitioned over to the use of EMR systems.  This full transition implies the storage of 
all medical data, including patient histories, clinician assessments, physical exam data, 
diagnostic and laboratory data, procedures data and treatment data.  The full transition 
also implies the use of the EMR system as the primary interface for the clinician to enter 
patient data into the hospital database.  However, no recent studies exist that describe 
the usage, completeness and accuracy of the data stored in these EMR systems. 
The use of EMR data for HCAI surveillance has many advantages.  Surveillance 
utilizing EMR data bypasses the need for paper records.   Collection of patient data via 
chart review requires an extended amount of time and labor and lends itself to error 
(Wright et al., 2009).  In human medicine, all EMR systems that allow for automated 
surveillance report a time-savings benefit (Wright, 2008).  In human medicine, 
reductions in time and labor as a result of automated surveillance have been reported to 
be as high as 60% for surgical-site infection surveillance efforts (Chalfine et al., 2006).  
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Reductions in time spent on bloodstream infection surveillance and urinary tract 
infections have also been reported (Wright, 2008).  In one study, automated 
surveillance detected 24% more HCAI when compared with traditional practitioner-
based surveillance (Evans et al., 2009).  Another study reported that voluntary physician 
reports of HCAI were only 59% sensitive while automated surveillance sensitivity was 
reported to be 91% (Bouam, Girou, Brun-Buisson, Karadimas, & Lepage, 2003).  
Specificity for voluntary physician reports of HCAI and automated surveillance were 
both 91% (Bouam et al., 2003). 
Patient rectal temperatures are an integral component of the patient physical 
exam and are often interpreted as indicators of a patient’s general health.  VTHs that 
have made full transitions to using EMR systems should contain a large amount of 
patient rectal temperature data.  Patient temperatures may be a useful indicator of 
infection.  One human study that looked at fever and respiratory complaints in patients 
visiting emergency rooms for influenza surveillance found that fever was a useful 
surrogate marker for incident influenza-attributable morbidity (Olson et al., 2007).  
Increases in fever and respiratory visits corresponded in timing and magnitude with 
laboratory-confirmed influenza (Olson et al., 2007).   
1.3 Conclusions 
This review shows that the burden of MRSP via canine carriers to veterinary 
teaching hospitals may vary be geographic location. Further, risk factors for MRSP 
colonization among different patient populations within a hospital are poorly understood. 
HCAI surveillance within VTHs are also lacking.  The EMR is a relatively new 
technology within the veterinary field and provide infection control professionals with 
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access to a large number of patient data.  Use of the EMR system within VTHs may 
provide novel techniques into HCAI surveillance and allow for improved detection of 
HCAI as well as an estimate for baseline rates of HCAI. 
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2 Prevalence and characterization of canine Methicillin-Resistant 
Staphylococcus pseudintermedius in a veterinary teaching hospital 
2.1 Summary 
Background: Staphylococcus pseudintermedius is a commensal organism in dogs and 
an opportunistic pathogen.  The emergence of methicillin-resistant S. pseudintermedius 
(MRSP) strains is of significant concern.  The prevalence of MRSP in dogs with varying 
risk factors for infection, as well as serial isolation, has not been extensively described.  
Hypothesis/Objective: To determine the prevalence and persistence of MRSP 
colonization in populations of dogs with different risk factors for infection seen at the 
Colorado State University Veterinary Teaching Hospital (CSU-VTH).   
Animals: Two hundred and forty-three dogs presented to the CSU-VTH. 
Methods: Swabs were obtained from colonization sites at enrollment and at a follow-up 
appointment whenever possible, owners completed a standardized questionnaire, and 
the medical record was examined.  Enriched cultures were performed to detect MRSP. 
Results: The overall prevalence of MRSP colonization at enrollment (9/243) was 4% 
and at follow-up (7/155) was 5%.  Dermatology patients had a significantly higher 
prevalence of colonization with MRSP compared to other groups. Colonization 
persistence in paired samples was seen in Dermatology patients only.  Colonization 
was not associated with hospitalization or recent antimicrobial use.   
Conclusions and Clinical Importance:  Prevalence of MRSP colonization and 
persistence was highest in Dermatology patients.  The overall prevalence of MRSP 
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colonization in dogs was low and similar to previous reports.  Hospitalization and recent 
antimicrobial use were not found to be risk factors for MRSP colonization. 
2.2 Introduction 
Staphylococcus pseudintermedius is a commensal bacterium of dogs in the 
Staphylococcus intermedius group that can be an opportunistic pathogen (Harvey & 
Noble, 1998).  It is the most commonly isolated bacterium from lesions of skin and ear 
infections (Bloom, 2014; Zur, Gurevich, & Elad, 2016) and surgical site infections in 
dogs (Turk, Singh, & Weese, 2015).  However, S. pseudintermedius can be isolated 
frequently from healthy dogs as well, at rates ranging from 46-92%, depending upon the 
sampling site and method of isolation employed (Bannoehr & Guardabassi, 2012).  
Common canine carriage sites of S. pseudintermedius include the anal region, rostral 
nares, and oral cavity (Devriese & De Pelsmaecker, 1987).  It is thought that resident 
bacteria from these and other carriage sites are the pathogen source in dogs in which 
opportunistic infections occur (Pinchbeck et al., 2006). 
The development of antimicrobial resistance in bacteria is a significant concern, 
both from an animal welfare and public health standpoint (Pomba et al., 2016).   One of 
the mediators of methicillin-resistance in staphylococci is the gene mecA, which codes 
for PBP2a, an altered penicillin-binding protein (PBP) inducing resistance to all beta-
lactam drugs (van Duijkeren et al., 2011).  The mecA gene is located on the 
staphylococcal chromosomal cassette (SCCmec), a mobile genetic element that is 
transmissible among staphylococcal species and was first discovered in S. aureus 
(Descloux, Rossano, & Perreten, 2008; Katayama, Ito, & Hiramatsu, 2000).  Because of 
this cassette’s mobility, it is not surprising that methicillin resistance mediated by mecA 
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has also emerged in S. pseudintermedius, appearing to be increasing in frequency 
since 2006 (Weese & van Duijkeren, 2010).   
Recent hospitalization and antimicrobial use have been reported to be risk 
factors for MRSP colonization and/or infection in dogs (Huerta et al., 2011; Nienhoff et 
al., 2011; Weese, Faires, Frank, Reynolds, & Battisti, 2012).  Contamination or 
colonization of clinic personnel and equipment as well as cross-infection of patients 
within a veterinary clinic have been demonstrated (Nazarali et al., 2015; van Duijkeren 
et al., 2008; Zubeir et al., 2007), underscoring the potential importance of S. 
pseudintermedius as a cause of hospital associated infections in dogs requiring 
vigilance in veterinary care settings.  While clinical human infections with MRSP appear 
to be rare, its importance as a potential zoonosis also deserves appropriate recognition 
of transmission risks (Somayaji et al., 2016).   
Colonization rates of methicillin-resistant S. pseudintermedius (MRSP) in healthy 
dogs are low (Bean & Wigmore, 2016; Beck et al., 2012; Griffeth et al., 2008; 
Hanselman et al., 2008; Vengust et al., 2006), but 34-66% of dogs with pyoderma 
and/or otitis are reported to be MRSP infected (Beck et al., 2012; Kawakami et al., 
2010; Siak et al., 2014; Weese et al., 2012).  A search of medical records for canine 
dermatology patients cared for at  Colorado State University Veterinary Teaching 
Hospital (CSU-VTH) in 2014-2015 using search terms of pyoderma, otitis, 
Staphylococcus, antimicrobial resistance (AMR), methicillin-resistant Staphylococcus 
aureus (MRSA) and Staphylococcus pseudintermedius identified a cumulative incidence 
of documented MRSP in only 2% of dermatology patients (37/1,917). While this 
suggests that there may be a relatively low risk of transmission of MRSP at the CSU-
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VTH,dogs can be colonized with MRSP without developing apparent infections. As 
such, this study was designed to evaluate the risk of colonization and persistence of 
carriage of MRSP in dogs that were presented for 3 different types of care at the CSU-
VTH. 
2.3 Materials and Methods 
2.3.1 Study overview 
A longitudinal study was conducted to estimate rates of colonization in dogs 
belonging to three different risk groups: those admitted to the Community Practice, 
Dermatology and Surgical Oncology services at the Colorado State University 
Veterinary Teaching Hospital (CSU-VTH).  Signalment and history was collected using 
a standardized questionnaire, and dogs were sampled on two occasions to identify 
colonization with MRSP.  Relationships between potential  risk factors and the 
likeilihood of colonization were assessed using logistic regression.  The methods used 
in this study were reviewed and approved by the Institutional Animal Care and Use 
Committee at Colorado State University (approval number 14-5079A). 
2.3.2 Study population 
The Community Practice, Surgical Oncology, and Dermatology Services were 
selected to represent groups of dogs predicted to have, respectively, low, moderate, 
and high risks for exposure, colonization, and infection with MRSP.  Each service 
enrolled eligible dogs based on convenience sampling during the study period. Dogs 
were eligible for the study if they presented to 1 of the 3 selected services during the 
period from October, 2014 through June, 2015.  Owner consent was obtained, and 
owners agreed to a follow-up sampling. 
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2.3.2.1. Community Practice 
Dogs enrolled through Community Practice were predicted to have a low risk of 
active infection or colonization.  Patients were eligible for inclusion in the study if the 
patient was presented for vaccination or another type of wellness appointment and had 
no history of receiving systemic antibiotics or visiting a veterinary hospital in the last 6 
months.  Owners who enrolled their dogs through Community Practice were given a 
financial incentive to return for follow-up sampling within 2 to 4 weeks. 
2.3.2.2. Surgical Oncology 
Patients enrolled through Surgical Oncology received planned surgery as part of 
the therapy for their cancer-related illness and stayed overnight  (≥ 12 hours) at the 
CSU-VTH.  They were considered to be at moderate risk for acquiring an infection 
during hospitalization, given they were undergoing invasive procedures and exposures 
to multiple hospital areas and departments during their treatment and potentially 
receiving antimicrobials.  Follow-up samples for patients enrolled through Surgical 
Oncology occurred one hour prior to discharge, i.e. both admission and follow-up 
samples occurred during the same hospital stay. 
2.3.2.3. Dermatology 
 Patients from the Dermatology service were considered to have a high risk of 
colonization and active infection because S. pseudintermedius is recognized as an 
important pathogen in dermatological disease in dogs.  Since these patients were being 
seen in a tertiary teaching hospital and their disease was likely chronic, it was also 
thought probable that they would have recently received antimicrobial drugs.  Dogs 
presenting to the Dermatology service were eligible for inclusion into the study if the 
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patient was presenting for first time or recheck appointment regardless of antimicrobial 
history or history of MRSP pyoderma.  Clients were instructed to return with their dogs 
in 2 to 4 weeks for a follow-up sample. 
2.3.3 Sample collection 
Patients enrolled in the study were sampled for MRSP colonization twice: once at 
enrollment and once at follow-up. 
Each patient was sampled at the nares, oral cavity, and anus using a different 
culturette swab for each site.  Sampling was performed by veterinary personnel working 
in the participating services, who were trained in order to standardize collection.  
Additionally, all services were provided with written instructions regarding inclusion 
criteria and sampling technique.  Clean nitrile exam gloves were worn when sampling.  
For sampling of the nares, culturette swabs were placed just inside the nares and gently 
rotated.  If the nares were too small to insert a swab, the nasal planum was swabbed 
instead.  For sampling of the oral cavity, culturette swabs were placed in the left and 
right maxillary and mandibular commissures at the junction of the gingiva and labial 
mucosa.  For sampling of the anus, the anal ring was swabbed circumferentially with a 
culturette swab.  Once sampling was complete, each swab was placed in commercial 
sample transport tubes containing Amies media, and the 3 tubes were placed into a 
plastic bag for transport to the laboratory.  Random numbers were generated and used 
to label samples to mask patient identification and medical histories were not available 
in order to blind laboratory personnel.   
A questionnaire was designed prior to the study to uniformly collect information 
regarding each patient.  The questionnaire was administered each time samples were 
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collected.  History pertaining to antimicrobial treatments (topical or oral) within the prior 
12 months, methicillin-resistant Staphylococcus infection history within the prior 12 
months and surgery or penetrating wound history within the prior 12 months were 
actively and uniformly obtained from the client as well as from the medical records from 
the CSU-VTH and referring veterinarian.  Antimicrobial history between sampling times 
was obtained at follow-up sampling, allowing for a prospective gathering of data. 
2.3.4 Laboratory methods 
Samples for each patient were pooled and placed in 10% salt-meat enrichment 
broth (HiMedia) (Chapman, 1945; Fairbrother & Southall, 1950; Maitland & Martyn, 
1948) and incubated at 37°C for 18 hours.  Samples were then placed on a screening 
agar containing oxacillin (2 µg/ml) and incubated at 37°C for 18-24 hours.  Three 
suspected staphylococcal colonies were selected from each plate, and streaked for 
isolation onto a blood agar plate and incubated at 37°C for 18-24 hours.  Suspect 
colonies were Gram-stained and tested for catalase reaction.  Identification of presumed 
MRSP colonies was confirmed using PCR to identify the nuc gene for S. 
pseudintermedius (Sasaki et al., 2007b, 2010) and also by matrix-assisted laser 
desorption/ionization time-of-flight spectrometry (MALDI-TOF).   
2.3.5 Data analysis 
Information regarding patient signalment, history, and laboratory testing results 
were entered in a computer spreadsheet.  Data were analyzed descriptively to 
summarize the prevalence of recovery of MRSP.  Proportions from paired samples were 
compared using McNemar’s test, and proportions for independent samples were 
compared using the chi-square test.  Width adjusted 95% confidence intervals (95%CI) 
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for binomial proportions were calculated, adding 2 successes and 2 failures to actual 
counts (Agresti & Coull, 1998). 
2.4 Results 
A total of 243 patients were enrolled in the study (Table 1); 60 dogs were 
enrolled through the Community Practice service, 71 dogs were enrolled through the 
Dermatology service and 112 dogs were enrolled through the Surgical Oncology 
service.  Patients enrolled through the Community Practice service were widely variable 
in age (Table 1), whereas a majority of patients enrolled through the Surgical Oncology 
service were > 7 years old, and a majority of patients enrolled through the Dermatology 
service, were > 2 years old. 
Dermatology was the only service with a majority of enrolled patients having 
received prior or current systemic or topical antimicrobial treatment within the previous 
12 months (72%; 51/71) compared to the Community Practice (5%; 3/60) or Surgical 
Oncology (37%; 41/112) services.  The proportion of patients with surgery or wounds 
within the previous 12 months was 8% (5/60) for Community Practice patients, 20% 
(14/71) for Dermatology patients and 34% (38/112) for Surgical Oncology patients.  
Four of the patients presented to Dermatology (4/71; 5%) and 1 of the patients 
presented to Surgical Oncology (1/112; 0.9%), for a total of 5/243 (2%), had been 
diagnosed with MRSP in the previous 12 months (Table 1). 
The proportion of MRSP colonization was 4% (9/243; 95% CI, 2% – 7%) at 
enrollment and 5% (7/156; 95% CI, 2% – 9%) at follow-up (Table 1).  Dermatology had 
the greatest proportion of patients, at 8 %, (6/71; 4% - 17%), that tested positive for 
MRSP at colonization sites (Fisher’s P-value < 0.05).  No patients enrolled through the 
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Community Practice service (0/60) were culture-positive for MRSP at colonization sites 
at the time of admission, and 3% (3/112) of patients enrolled through the Surgical 
Oncology service were positive (Table 2).  History of prior surgery or penetrating wound, 
antimicrobial drug treatment, or prior MRSP infection was not associated with the 
likelihood of being culture positive at the time of admission (P > 0.05). 
Paired samples (i.e., at enrollment and follow-up) were collected from 64% 
(155/243) of enrolled patients.  Among patients that had both paired samples, 94% 
(145/155; 95% CI, 89% – 96%) cultured negative at both time points, 5% (7/155; 95% 
CI, 2% – 9%) were cultured positive at 1 time point (either at enrollment or follow-up) 
and 2% (3/155; 95% CI, 0% – 6%) cultured positive at both time points.  For patients 
that cultured positive at enrollment only, 1 patient (33%; 1/3; 95% CI, 0% - 4%) had a 
surgical procedure or penetrating wound within the prior 12 months to enrollment and 
only 1 patient (33%; 1/3; 95% CI, 0% - 4%) received antimicrobials within the 12 months 
prior to enrollment.  None of these patients were diagnosed with MRSP within the 
previous 12 months.  For patients that cultured positive only at follow-up, 1 (25%; 1/4; 
95% CI, 0% - 4%) patient underwent surgery or had a penetrating wound within the 12 
months prior to enrollment, 1 (25%; 1/4; 95% CI, 0% - 4%) patient had been treated with 
antimicrobials within the prior 12 months to enrollment, and 2 (50%; 2/4; 95% CI, 0% - 
5%) patients had received antimicrobials between enrollment and follow-up.  None of 
these patients had a history of MRSP within the prior 12 months.  All 3 patients that 
cultured positive at both enrollment and follow-up were Dermatology patients and had 
received antimicrobials within the 12 months prior to enrollment; 1 (33%; 1/3; 95% CI, 
0% - 13%) patient had received antimicrobials between enrollment and follow-up.  None 
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of these patients had a history of MRSP infections or surgery or penetrating wounds 
within the 12 months prior to enrollment. 
Among patients with paired samples, there was no difference in the proportion 
that were culture-positive at admission compared to those that were culture-positive at 
follow-up (McNemar’s P-value = 1.0). The proportion of study subjects from which 
paired samples were collected was notably higher for the Surgical Oncology patients 
(79%; 88/112; 95% CI, 70% – 85%) in comparison to the Dermatology patients (58%; 
41/71; 95% CI, 46% - 69%) and the Community Practice patients (45%; 27/60; 95% CI, 
33% – 58%). 
MRSA was isolated from colonization sites from 4 patients on the first sampling; 
3 were enrolled through Dermatology and 1 through Surgical Oncology.  All of these 
patients had a history of antimicrobial use in the past 12 months but had not been 
previously diagnosed with resistant staphylococci.  One of the Dermatology patients 
was co-colonized with MRSP.  This patient also had a history of surgery or wound in the 
last 12 months.  MRSA was isolated from one Community Practice patient on the follow-
up sample; this patient was also co-colonized with MRSP at this time and had not been 
colonized with either MRSP or MRSA on the enrollment sample.  Since this patient was 
a Community Practice patient, it did not have hospitalization or antimicrobial use risk 
factors.   
2.5 Discussion 
Results of this study suggest that the burden of MRSP colonization in  canine 
patients at the CSU-VTH was, regardless of the predicted risk of the population, 
relatively low (Table 2), similar to previous reports of MRSP colonization in the United 
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States (Detwiler et al., 2013; Hanselman et al., 2008).  This lower burden of colonization 
is consistent with the inference obtained from evaluating documented diagnosis of 
MRSP infections among dermatology patients treated at the CSU-VTH prior to this 
study (data not shown).  While the goal of this study was to characterize MRSP 
colonization, culture methods used in this study also allowed detection of MRSA, and 
the prevalence of colonization with this zoonotic pathogen was also very limited. 
While all clients agreed to return for follow-up sampling at the time they enrolled 
their dogs, and despite attempts to contact all participating clients, follow-up sampling 
was less complete than anticipated.  Not surprisingly, follow-up sampling was most 
complete for Surgical Oncology patients where both samples were obtained within the 
same hospital stay.  The services utilized a convenience sampling strategy rather than 
random sampling, which could have created an enrollment bias; however,enrolling 
personnel were unaware of MRSP colonization status at time of enrollment suggesting 
that this bias was unlikely to affect results. As predicted, this study suggests that healthy 
patients (represented by those enrolled through the Community Practice service) were 
less likely to carry MRSP.  In addition, Surgical Oncology patients, despite their 
increased exposure to multiple areas of the hospital environment during their 
hospitalization, did not have a higher risk of acquisition of MRSP compared to the other 
populations and also did not exhibit persistence of colonization.  Because of the high 
number of dogs that were Surgical Oncology patients for which paired samples were 
obtained, it would seem likely that acquisition of MRSP between enrollment and 
discharge would have been detected. 
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Although prevalence was lower than in some recent reports, this study supports 
the impression that patients with dermatological disease may be at higher risk of MRSP 
colonization (Beck et al., 2012; Kania et al., 2004). Dermatology patients had a 
significantly higher proportion of MRSP colonization for both enrollment samples and 
follow-up samples (Table 2) compared to the other populations.  Based on paired 
samples collected, colonization persistence among patients also only occurred among 
those enrolled by the Dermatology service (Appendix 2).  History of MRSP infection did 
not preclude enrollment, but this was not associated with colonization during this study. 
However, since Dermatology patients tended to be more likely to have colonization that 
persisted for at least 2 to 4 weeks compared to the other populations, this suggested 
that colonization tends to be more transient in non-dermatological patients.  These 
results are in contrast to the findings of Windahl et al. (2012), who reported that the 
overall median length of MRSP carriage in dogs with a history of clinical MRSP infection 
was 11 months and the duration of carriage was not affected by the presence of 
wounds or dermatological disease.   
Association of recent antimicrobial treatment with MRSP colonization and 
infection has been mixed in previous studies (Beck et al., 2012; Weese et al., 2012).  
This study did not find an association between previous antimicrobial use and MRSP 
colonization.  This study also did not find an association between hospitalization in the 
Surgical Oncology patients and MRSP colonization, while previous studies have found 
an association between hospitalization and MRSP colonization (Nienhoff et al., 2011).  
It is possible that the low overall prevalence of MRSP colonization in canine patients 
admitted to the CSU-VTH makes it less likely for dogs to nosocomially acquire MRSP in 
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this particular veterinary care setting.  The possibility of false negatives obtained in the 
culture process for the colonization samples should also be considered; however, the 
cultures of the lesions in the dermatological patients were performed in the clinical 
laboratory serving the CSU-VTH and demonstrated a similar low prevalence. 
In humans, colonization by MRSA is a known risk factor for subsequent MRSA 
infection and associated sequelae (Huang & Platt, 2003).  It stands to reason that 
MRSP colonization in dogs is a likely risk factor for subsequent MRSP infection.  In fact, 
such an association has been shown for pre-operative MRSP-colonized dogs receiving 
tibial plateau leveling osteotomies (TPLO) surgeries and post-operative surgical site 
infection by MRSP (Nazarali et al., 2015).  Based on this information and our study 
results, dermatologic patients should be potentially considered to be at higher risk of 
complications associated with MRSP infection sequelae when undergoing surgical 
procedures such as TPLO due to their relatively high rate of more persistent 
colonization.  In addition, these patients should be considered to be at a relatively 
higher risk of being a reservoir of MRSP for transmission to in-contact animals and 
people and contamination of the environment. 
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2.6 Tables 
Table 1 - Demographics of enrolled patients 
Characteristics 
Total (n = 243) Community Practice (n = 60) Dermatology (n = 71) Surgical Oncology (n = 112) 
Number (%) 95% CI (%) Number (%) 95% CI (%) Number (%) 95% CI Number (%) 95% CI 
Age < 2 years 32 (13) (9, 18) 24 (40) (29, 53) 6 (8) (4, 17) 2 (2) (0, 6) 
2 - 7 years 65 (27) (22, 33) 18 (30) (20, 43) 31 (44) (33, 55) 16 (14) (9, 22) 
> 7 years 146 (60) (54, 66) 18 (30) (20, 43) 34 (48) (37, 59) 94 (84) (76, 90) 
Sex Intact female 8 (3) (2, 6) 4 (7) (3, 16) 1 (1) (0, 8) 3 (3) (1, 8) 
Spayed female 97 (40) (34, 46) 23 (38) (27, 51) 32 (45) (34, 57) 42 (38) (29, 47) 
Intact male 11 (5) (3, 8) 8 (13) (7, 24) 1 (1) (0, 8) 2 (2) (0, 6) 
Castrated male 127 (52) (46, 58) 25 (42) (30, 54) 37 (52) (41, 63) 65 (58) (49, 67) 
AMD
1
 Yes 95 (39) (33, 45) 3 (5) (2, 14) 51 (72) (60, 81) 41 (37) (28, 46) 
No 148 (61) (55, 67) 57 (95) (86, 98) 20 (28) (19, 40) 71 (63) (54, 72) 
MRSP Infection
2
 Yes 5 (2) (1, 5) 0 (0, 6) 4 (6) (2, 14) 1 (1) (0, 5) 
No 232 (95) (92, 97) 60 (100) (94, 100) 66 (93) (85, 97) 106 (95) (89, 98) 
Unknown 6 (2) (1, 5) 0 (0, 6) 1 (1) (0, 8) 5 (4) (2, 10) 
Surgery/Wound
3
 Yes 57 (23) (19, 29) 5 (8) (4, 18) 14 (20) (12, 30) 38 (34) (26, 43) 
No 186 (77) (71, 81) 55 (92) (82, 96) 57 (80) (70, 88) 74 (66) (57, 74) 
AMD = antimicrobial drug; MRSP = methicillin-resistant Staphylococcus; CI = confidence interval 
1
Patients that received antimicrobial treatment within 12 months prior to enrollment. 
2
Patients that had a methicillin-resistant Staphylococcus infection within 12 months prior to enrollment 
3
Patients that had surgery or penetrating wound with 12 months prior to enrollment.  
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Table 2 - Proportion of MRSP positive samples at enrollment and follow-up 
Enrollment Samples Follow-up Samples 
Study Group n MRSP Positive (%) 95% CI (%) n MRSP Positive (%) 95% CI (%) 
Community 
Practice 
60 0 (0, 6) 27 1 (4) (1, 18) 
Dermatology 71 6 (8) (4, 17) 41 4 (10) (4, 23) 
Surgical 
Oncology 
112 3 (3) (1, 8) 87 2 (2) (1, 8) 
Total 243 9 (4) (2, 7) 155 7 (5) (2, 9) 
MRSP = Methicillin-resistant Staphylococcus pseudintermedius; CI = Confidence interval 
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3 Fevers detected in canine patients after admission to a veterinary teaching 
hospital using electronic medical record data 
3.1 Summary 
Background: The ability to identify healthcare-associated infections (HCAI) in 
veterinary hospitals is frequently hampered by limited surveillance capability. Rectal 
temperatures are commonly recorded in electronic medical record (EMR) databases for 
all patients.  Since post-admission fever may be an indication of HCAI, electronic 
records of rectal temperatures may assist in HCAI surveillance. 
Hypothesis/Objective: To estimate the incidence of post-admission fevers in 
hospitalized canine patients at the Colorado State University Veterinary Teaching 
Hospital (CSU-VTH) and associations with type of patient care and duration of 
hospitalization.  
Study Population: Six thousand four hundred and sixty-nine canine patients 
hospitalized between January 1, 2012 and June 30, 2015 at the CSU-VTH.   
Methods: Retrospective study. Patient data were extracted from the EMR database, 
summarized, and analyzed to assess associations between fever after admission and 
patient variables.    
Results: The estimated cumulative incidence of fevers after admission was 9%.  There 
were positive associations between the development of post-admission fever and 
complicated case management requiring multiple services (OR = 1.3; 95% CI = 0.9 – 
1.9) and hospitalization >2 days (OR = 2.4; 95%; CI = 2.0 – 2.9). 
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Conclusions and Clinical Importance: Rectal temperatures in EMR databases may 
provide useful information for HCAI surveillance. 
3.2 Introduction 
Control of healthcare-associated infections (HCAI) is critically important to the 
delivery of the highest quality care in veterinary hospitals (Morley, 2013; Morley et al., 
2013). The adverse impacts of HCAI on human and veterinary healthcare are well 
known (Calfee, 2012; Klevens, 2007; Morley, P.S. 2013) as well as the beneficial effect 
of surveillance in reducing their incidence (Benedict, Morley, & Metre, 2008; Pearson, 
2009).  However, implementation of HCAI surveillance programs in veterinary hospitals 
has frequently been a challenge for several reasons.  There is limited information 
available regarding risk factors for healthcare-associated infections (HCAI) in veterinary 
medicine (Benedict et al., 2008; Burgess & Morley, 2015; Morley, 2013; Ruple-Czerniak 
et al., 2013).  Without such information, it is difficult to logically target appropriate 
surveillance efforts.  In a patient population of various species with different 
susceptibilities to numerous potential pathogens, it is difficult to select which specific 
HCAI should be monitored.  Additionally, the veterinary profession has an incomplete 
understanding of acceptable rates of HCAIs, frequently because hospitals do not 
perform comprehensive surveillance to establish baseline rates.   
Syndromic surveillance, or the measurement of non-specific indicators of disease 
such as fever of undetermined origin, diarrhea and/or vomiting, or intravenous catheter 
site inflammation, is a system for monitoring the health of a population that can be used 
to estimate rates of HCAI (Ruple-Czerniak et al., 2013).  Rather than targeting a specific 
pathogen requiring laboratory confirmation, syndromic surveillance allows the “casting 
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of a wide net” to identify patients manifesting any clinical signs that could be indicative 
of an HCAI. The increasing availability and use of electronic medical record (EMR) 
systems has the potential to facilitate the implementation of syndromic surveillance 
programs for HCAIs by bypassing the manual extraction of patient parameters from 
handwritten medical records.  The Colorado State University Veterinary Teaching 
Hospital (CSU-VTH) has been utilizing an EMR to record patient data, including rectal 
temperatures, since 2010.   
The purpose of this study was to determine the cumulative incidence of post-
admission fevers in hospitalized canine patients at the CSU-VTH and assess whether 
the occurrence of a post-admission fever was associated with type of patient care or 
duration of hospitalization.  It was hypothesized that dogs with more severe disease, 
complex case management, and longer duration of hospitalization would be at higher 
risk of developing a fever of unknown origin after admission to the hospital. 
3.3 Materials and methods 
3.3.1 Study Overview 
A retrospective longitudinal study was used to estimate the frequency that fevers 
were detected after admission among dogs hospitalized at the CSU-VTH.  Patient data 
were obtained from an EMR system that was custom designed for use at this hospital 
for admissions occurring between January 1, 2012, and June 30, 2015. Visits were 
classified by the service providing care as a proxy for type of illness.  Data were 
summarized, and logistic regression was used to investigate associations between the 
outcome of interest (fever after arrival) and two exposure variables of interest (type of 
patient care, and duration of hospitalization categorized as ≤2 days or <2 days). 
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3.3.2 EMR Description 
The EMR system used during the study period was a customized computer 
system designed for use at the CSU-VTH (VetPoint©, College of Veterinary Medicine & 
Biomedical Sciences, Colorado State University).  Patient information was entered into 
standardized web-based forms by care providers, and data were stored in relational 
databases on computers located at Colorado State University.  Each patient was 
assigned a unique identifying number within the medical records system (“case 
number”), and each patient visit was also assigned a unique identifying number 
(“invoice number”) which was linked to charges recorded within the CSU-VTH 
accounting system.  Rectal temperatures were recorded along with other physical 
examination (PE) findings on a standardized PE form. Charges for services and 
materials that were used in the care of patients were recorded within the accounting 
system by the different hospital services (cost-centers) within the CSU-VTH (e.g. 
Internal Medicine, Surgery, Oncology, Emergency and Critical Care (ECC) services 
(including both Urgent Care and Critical Care), Anesthesiology, Cardiology and 
Cardiovascular Surgery, Community Practice, Dentistry and Oral Surgery, Dermatology, 
Ophthalmology, Radiation Therapy, Sports Medicine, Diagnostic Imaging, Bacteriology, 
Clinical Pathology, etc.).  The link between charges invoiced by the different service 
centers and the unique invoice numbers were used to classify patients with regard to 
the type of care that they received.   
Ideally, for use in a computerized surveillance system, temperatures would have 
been recorded in a standard fashion, in a single field.  However, in actual practice, 
temperatures are measured and recorded in a variety of places in the medical records.  
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While specific fields for recording rectal temperatures were only contained within the 
physical examination (PE) forms, rectal temperatures were sometimes also recorded in 
other comment or free-text fields which were not searchable in a systematic fashion.  
The PE forms were required to be associated with a subjective-objective-assessment-
plan (SOAP) form, and there was only a single PE form available per SOAP form.  In 
addition to rectal temperatures, other data that could be entered into the PE forms, e.g. 
attitude, capillary refill, hydration status, were not available for analysis.  While multiple 
SOAP forms could be completed for patients on each hospitalization day, it was very 
infrequent that multiple SOAP form were opened on any given day to capture patient 
information.  As such, there was typically only a single rectal temperature recorded per 
patient per day.   
3.3.3 Inclusion criteria and case definition 
Medical record databases were searched to identify all dogs that were admitted 
to the CSU-VTH between January 1, 2012 and June 30, 2015, were hospitalized for ≥ 1 
night, documented as being afebrile (≤102.5°F or ≤39.2°C) at admission, and had rectal 
temperatures recorded ≥ 1 additional time during the same hospitalization period (i.e., 
the rectal temperatures must have been recorded at least twice during hospitalization).  
Patients that subsequently developed a fever (>102.5°F or >39.2°C) after admission 
were identified as having the outcome of interest.   
3.3.4 Type of patient care and duration of hospitalization 
Visits were classified by the service providing care as a proxy for type of illness, 
disease severity, complexity of case management (i.e. number of involved personnel), 
and likelihood of invasive procedures.  Patients were divided into 7 different categories: 
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Medicine, Oncology, Surgery, Medicine and Emergency and Critical Care (ECC), 
Oncology and ECC, Surgery and ECC, and Other.  Patients who were seen by ECC 
likely had more severe disease and exposure to additional personnel than patients not 
seen by ECC.  Patients were classified in the “Other” category if they were cared for by 
ECC in combination with not just one, but at least two of the Oncology, Surgery, and 
Medicine Services and potentially additional specialty services as well, indicating that 
these patients had the most complex disease.    
Patients that were cared for by Cardiology and Cardiovascular Surgery and 
Neurology service centers were classified as Internal Medicine cases for the purposes 
of analysis in this study.  Patient visits in which the associated care centers only 
included diagnostic services (e.g. Radiology, Bacteriology, Clinical Pathology) with no 
additional involvement by at least one Primary, Specialty, Outpatient or ECC service, 
were excluded.   
Duration of hospitalization was determined using financial databases and client 
charges for hospitalization.   
3.3.5 Analysis 
Extracted data were summarized in computer databases, and analyzed to 
characterize the risk for fever occurrence after admission.  Additionally, analyses were 
conducted to compare the risk of fever after admission in different patient groups, and to 
evaluate whether fever occurrence was associated with duration of hospitalization.  The 
case type categories were used to create mutually exclusive classification variables that 
were used in multivariable logistic regression models (Table 3).  Patient demographic 
information was analyzed descriptively, and the cumulative incidence of fevers that 
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were recognized after admission was calculated.  Repeated measures multivariable 
logistic regression was used to investigate a priori hypothesis that occurrence of fevers 
were associated with duration of hospitalization and the type of care that patients 
received (alpha = 0.05) (R, R Core Team 2013).  For the purpose of this analysis, 
duration of hospitalization was classified dichotomously (≤2 days, or >2 days).  Odds 
ratios (OR), confidence intervals (CI) and p-values were calculated using the results of 
the multivariable logistic regression models.   
3.4 Results 
The initial dataset extracted from the EMR contained 84,608 unique patient visits 
for dogs.  After excluding visits where patients were not hospitalized at the VTH, 11,345 
(13%) unique visits remained.  Visits where the patient was not seen by a primary care 
service were further excluded, leaving 11,251 unique visits eligible for inclusion into the 
study.  Finally, after exclusion of visits with <2 rectal temperature records in the EMR or 
visits where the temperature taken at admission was febrile were excluded, 6,469 (8%) 
unique visits were included in the study.  Fevers that developed after admission (with 
afebrile temperatures at admission) were reported for 9% (588/6,469) of patient visits 
during the study period.  
Of these 6,469 patients, 297 (5%) were intact females, 2,835 (44%) were spayed 
females, 438 (7%) were intact males, and 2,895 (45%) were neutered males (Table 1).  
Medicine patients comprised 4% (225/6,469), 20% (1,226/6,469) were Medicine cases 
with ECC involvement, 8% (516/6,469) were Surgery cases, 16% (1,064/6,469) were 
Surgery cases with ECC involvement, 5% (346/6,469) were Oncology cases, 8% 
(519/6,469) were Oncology cases with ECC involvement, and 40% (2,573/6,469) were 
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cases classified as Other. The length of stay for 79% (5,079 /6,469) of patient visits was 
≤ 2 days.  The 5 most commonly enrolled breeds were mixed breeds (27%; 1,778 
/6,469), Labrador Retrievers (10%; 633/6,469), Golden Retrievers 4%; 278/6,469), 
Chihuahuas (3%; 217/6,469) and Staffordshire terriers (2%; 159/6,469) (Table 1).  
Other breeds that made up the top 70% of enrolled dogs included dachshunds, German 
Shepherds, boxers, Australian shepherds, beagles, huskies, border collies, shih tzus, 
beagles, Yorkshire terriers, Australian cattle dogs, English bulldogs, Jack Russell 
terriers, miniature schnauzers, and Rottweilers.  The breeds of the remaining dogs 
made up 31% (1,945/6,469) of the enrolled patient population.  
Controlling for the duration of hospitalization, there were significant differences in 
the risk of developing fevers after admission among patients cared for by different 
services (P-value < 0.001, Table 3).  Patients in the “Other” category (with the most 
complex case management) had the highest risk of developing a fever of unknown 
origin. (OR = 1.31, CI = 0.93 – 1.85).  Cases seen by Medicine alone had the lowest risk 
of fever (OR = 0.37, CI = 0.17-0.80) (Table 3).     
Controlling for differences in services managing the cases, duration of 
hospitalization was also associated with the odds of developing fevers after admission. 
Patients hospitalized for > 2 days had over twice the odds of developing fevers after 
admission compared to those hospitalized for 1-2 days (OR 2.4; 95%CI=2.0-2.9; 
P-value < 0.001).
3.5 Discussion 
This study demonstrated that canine patients with critical illness and complex 
case management that were hospitalized for greater than 2 days had an increased risk 
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of developing fever of unknown origin.  Fever of unknown origin has been previously 
associated with HCAI in canine patients in critical care units of small animal hospitals 
(Ruple-Czerniak et al., 2013).  The positive association of fever with duration of 
hospitalization is consistent with previous studies that showed similar associations 
between increased length of stay and HCAI acquisition (Eugster, Schawalder, Gaschen, 
& Boerlin, 2004; Smarick et al., 2004).  Patients that have longer hospital stays are 
likely to have more severe illness, but it also creates opportunities for increased 
exposure to infectious agents within the hospital environment. Case complexity, i.e., the 
involvement of more than one service in the care of the patient, increases the exposure 
of the patient to numerous personnel and areas of the hospital, potentially increasing 
exposure to nosocomial pathogens.  Therefore, it stands to reason that case complexity 
would increase risk for the development of HCAI.   
This study also shows that the EMR could potentially help identify risk of HCAI 
due to other patient populations.  While the current study focuses on hospitalized 
patients, the EMR reveals that the vast majority of patients that visit the VTH are not 
hospitalized (87%; 73,263/84,608).  While the risk of HCAI acquisition to non-
hospitalized patients is likely lower than that of patients who are hospitalized, non-
hospitalized patients may pose an infectious risk to other patients.  EMR data can also 
be used to understand the infectious risk from patients febrile at admission.  Of the visits 
where the patient was hospitalized under the care of a primary service, 27% 
(3,052/11,251) of these patients were febrile upon admission.  While these visits were 
not the focus of this study and were ultimately excluded, these patients could be a 
source of infection to other patients in the hospital. 
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This study did not specifically examine the association between fevers after 
admission and HCAIs.  This association was difficult to examine because there is 
currently no method of indicating HCAI occurrence in VTH patients in the EMR.  A fever 
identified after admission may be a part of the presenting patient’s disease process and 
not necessarily due to HCAI.  Another study limitation is that, while multiple 
temperatures are often collected per patient visit per day, typically only one temperature 
per day was entered into the EMR.  Rectal temperatures are subject to variation 
throughout the day.  It is possible that, with only one temperature per day per patient 
visit available in the EMR, the number of fevers after admission may be underestimated. 
Anecdotally, the greatest hindrance to consistent patient data entry was the 
complexity of the patient data entry process of the EMR.  While ease of data entry was 
not evaluated in this study, it is reasonable that less frequent recordings of patient data 
will occur if the entry process is complicated.  Patient data such as rectal temperatures, 
where variation throughout the day is to be expected, requires frequent collection and 
entry into the EMR.  In contrast, other syndromes used in surveillance for HCAI, such as 
IV catheter site inflammation, urinary tract inflammation, acute respiratory disorders, GI 
disorders or surgical site inflammation could be entered once a day without the 
anticipation of loss of sensitivity (Ruple-Czerniak et al., 2013). 
This study demonstrates the potential use of the EMR in a veterinary teaching 
hospital for retrospective syndromic surveillance in hospitalized patients to identify 
HCAI.  Further work to support the correlation of HCAI with fever of unknown origin and 
other syndromes will be helpful to validate this approach.  In addition, the exploration of 
methods to increase ease of data entry into the EMR and add “check-box” areas for 
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syndromic surveillance will be useful for these types of studies.  This study also 
identified the risk factors of duration of hospitalization and complex case management 
with the development of fever, a potential indicator of HCAI. 
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3.6 Tables 
Table 3 - Patient demographics for study subjects (n = 6,469) 
Characteristics 




= 225) (%) 
Internal 
Medicine + 
ECC (n = 
1226) (%) 
Surgery (n = 
516) (%)
Surgery + 
ECC (n = 
1064) (%) 
Oncology (n 
= 346) (%) 
Oncology + 
ECC (n = 
519) (%)
Other (n = 
2573) (%) 
Sex Intact female 297 (5) 8 (4) 46 (4) 35 (7) 65 (6) 10 (3) 5 (1) 128 (5) 
Spayed female 2835 (44) 106 (47) 571 (47) 239 (46) 430 (40) 153 (44) 228 (44) 1108 (43) 
Intact male 438 (7) 21 (9) 90 (7) 35 (7) 100 (9) 18 (5) 24 (5) 150 (6) 
Neutered male 2895 (45) 90 (40) 518 (42) 206 (40) 468 (44) 165 (48) 262 (50) 1186 (46) 
 
Undetermined 4 (0) 0 (0) 1 (0) 1 (0) 1 (0) 0 (0) 0 (0) 1 (0) 
Length of 
stay ≤ 2 days 
5079 (79) 188 (84) 754 (62) 492 (95) 723 (68) 279 (81) 375 (72) 2268 (88) 
> 2 days 1390 (21) 37 (16) 472 (38) 24 (5) 341 (32) 67 (19) 144 (28) 305 (12) 
Breed Mix 1778 (27) 60 (27) 263 (21) 137 (27) 194 (18) 92 (27) 117 (23) 915 (36) 
Labrador 633 (10) 20 (9) 90 (7) 73 (14) 118 (11) 56 (16) 73 (14) 203 (8) 
Golden retriever 278 (4) 8 (4) 36 (3) 29 (6) 64 (6) 37 (11) 46 (9) 58 (2) 
Chihuahua 217 (3) 8 (4) 21 (2) 5 (1) 16 (2) 1 (0) 2 (0) 164 (6) 
Staffordshire 159 (2) 3 (1) 16 (1) 9 (2) 14 (1) 4 (1) 5 (1) 108 (4) 
Dachshund 150 (2) 14 (6) 49 (4) 0 (0) 49 (5) 0 (0) 5 (1) 33 (1) 
German Shepherd 145 (2) 2 (1) 30 (2) 17 (3) 29 (3) 5 (1) 12 (2) 50 (2) 
Boxer 132 (2) 7 (3) 19 (2) 7 (1) 12 (1) 7 (2) 20 (4) 60 (2) 
Australian
shepherd
114 (2) 1 (0) 17 (1) 9 (2) 18 (2) 9 (3) 6 (1) 54 (2) 
Husky 103 (2) 3 (1) 13 (1) 11 (2) 21 (2) 8 (2) 8 (2) 39 (2) 
Border collie 102 (2) 1 (0) 24 (2) 6 (1) 14 (1) 2 (1) 4 (1) 51 (2) 
Shih tzu 102 (2) 3 (1) 28 (2) 5 (1) 20 (2) 1 (0) 6 (1) 39 (2) 
Beagle 100 (2) 3 (1) 18 (1) 6 (1) 16 (2) 3 (1) 15 (3) 39 (2) 
Yorkie 99 (2) 1 (0) 23 (2) 9 (2) 25 (2) 0 (0) 2 (0) 39 (2) 
Australian cattle
dog
87 (1) 0 (0) 14 (1) 4 (1) 14 (1) 1 (0) 6 (1) 48 (2) 
English bulldog 86 (1) 0 (0) 16 (1) 3 (1) 33 (3) 3 (1) 11 (2) 20 (1) 
Jack Russell terrier 82 (1) 4 (2) 13 (1) 3 (1) 14 (1) 3 (1) 2 (0) 43 (2) 
Miniature
Schnauzer
82 (1) 2 (1) 24 (2) 4 (1) 14 (1) 1 (0) 6 (1) 31 (1) 
Rotweiler 75 (1) 3 (1) 19 (2) 11 (2) 9 (1) 5 (1) 11 (2) 17 (1) 
Other 1945 (31) 82 (45) 493 (41) 168 (35) 370 (37) 108 (31) 162 (31) 562 (22) 
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Table 4 – Visits categorized by case type and ECC involvement 
Services Providing Care Counts 
Medicine 225 
Medicine + critical care 1226 
Oncology 346 
Oncology + critical care 519 
Surgery 516 
Surgery + critical care 1064 




Table 5 - Results of multivariable analysis with occurrence of fever after admission among canine visits to the 
VTH against case type and length of stay by patient in hospital 
Variables Category Total OR 95% CI p-value
Case Type Medicine 225 0.37 0.17 - 0.80 
< 0.001 
Medicine + critical care 1226 0.94 0.65 - 1.37 
Oncology 346 0.35 0.18 - 0.67 
Oncology + critical care 519 0.69 0.43 - 1.10 
Surgery + critical care 1064 0.72 0.48 - 1.07 
Other 2573 1.31 0.93 - 1.85 
Surgery 516 Ref. 
Length of Stay > 2 days 1390 2.39 1.99 - 2.88 
< 0.001 
≤ 2 days 5079 Ref. 
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4 Conclusions 
This study provides a baseline estimate of the prevalence of canine MRSP 
colonization upon admission to the CSU-VTH (4%).  This estimate falls within the range 
of previous reports about MRSP colonization.  This study also shows that the greatest 
prevalence of MRSP colonization is among patients presenting to the VTH for skin 
disease, compared to surgical oncology or community practice patients.  This group 
was also the only group to demonstrate colonization persistence.  In this study, no 
healthy patients presented with a positive MRSP colonization status.  Cancer patients 
receiving surgical procedures had a prevalence of MRSP colonization between healthy 
patients and patients presenting for skin disease, suggesting that cancer patients 
receiving surgical procedures may be more likely to present as MRSP carriers, but less 
likely than patients presenting for skin disease.   
This study also shows that fevers after admission are associated with known risk 
factors for HCAIs and may be a useful measure in a syndromic approach to HCAI 
surveillance.  Cases with the most complex management had an increased odds of 
having a fever after admission.  Also, visits with a longer duration of stay in the hospital 
had an increased odds of having a fever after admission.   
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Table 6: MRSP prevalence at carriage sites at enrollment	

























- 0 (0, 6) 5 (8) (4, 18) 3 (5) (2, 14) 60 (100) (94, 100) 
+ 0 (0, 6) 0 (0, 6) 0 (0, 6) 0 (0, 6) 

























- 4 (6) (2, 14) 12 (17) (10, 27) 47 (66) (55, 76) 65 (92) (83, 96) 
+ 0 (0, 5) 2 (3) (1, 10) 4 (6) (2, 14) 6 (8) (4, 17) 

























- 0 (0, 3) 36 (32) (24, 41) 39 (35) (27, 44) 109 (97) (92, 99) 
+ 1 (1) (0, 5) 2 (2) (0, 6) 2 (2) (0, 6) 3 (3) (1, 8) 
MRSP = Methicillin-resistant Staphylococcus pseudintermedius; AMD = Antimicrobial drug history; CI = 
Confidence interval 
1
Patients that had a MRSP infection within 12 months prior to enrollment 
2
Patients that had surgery or wound within 12 months prior to enrollment 
3
Patients that received antimicrobial treatment within 12 months prior to enrollment 
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 AMD prior to enrollment
3
 AMD between sampling4 Total (%) 
Number (%) 95% CI Number (%) 95% CI Number (%) 95% CI Number (%) 95% CI Number (%) 95% CI 
- - 2 (1) (0, 5) 34 (22) (16, 29) 57 (37) (30, 45) 98 (63) (55, 70) 145 (94) (89, 96) 
- + 0 (0,  2) 1 (1) (0,  4) 1 (1) (0,  4) 2 (1) (0, 5) 4 (3) (1, 6) 
+ - 0 (0,  2) 1 (1) (0,  4) 1 (1) (0,  4) 3 (2) (0, 6) 3 (2) (0, 6) 
+ + 0 (0,  2) 0 (0,  2) 3 (2) (0, 6) 1 (1) (0,  4) 3 (2) (0, 6) 







 AMD prior to enrollment
3










Number (%) 95% CI (%) 
- - 0 (0, 12) 1 (4) (1, 18) 1 (4) (1, 18) 0 (0, 12) 26 (96) (82, 99) 
- + 0 (0, 12) 0 (0, 12) 0 (0, 12) 0 (0, 12) 1 (4) (1, 18) 
+ - 0 (0, 12) 0 (0, 12) 0 (0, 12) 0 (0, 12) 0 (0) (0, 12) 
+ + 0 (0, 12) 0 (0, 12) 0 (0, 12) 0 (0, 12) 0 (0) (0, 12) 






 AMD prior to enrollment
3










Number (%) 95% CI (%) 
- - 2 (5) (1, 16) 6 (15) (7, 28) 25 (61) (46, 74) 27 (66) (51, 78) 35 (85) (72, 93) 
- + 0 (0, 9) 0 (0, 9) 1 (2) (0, 13) 0 (0, 9) 1 (2) (0, 13) 
+ - 0 (0, 9) 0 (0, 9) 1 (2) (0, 13) 2 (5) (1, 16) 2 (5) (1, 16) 
+ + 0 (0, 9) 0 (0, 9) 3 (7) (3, 19) 1 (2) (0, 13) 3 (7) (3, 19) 







 AMD prior to enrollment
3










Number (%) 95% CI (%) 
- - 0 (0, 4) 27 (31) (22, 41) 31 (36) (26, 46) 71 (82) (72, 88) 84 (97) (90, 99) 
- + 0 (0, 4) 1 (1) (0, 6) 0 (0, 4) 2 (2) (1, 8) 2 (2) (1, 8) 
+ - 0 (0, 4) 1 (1) (0, 6) 0 (0, 4) 1 (1) (0, 6) 1 (1) (0, 6) 
+ + 0 (0, 4) 0 (0, 4) 0 (0, 4) 0 (0, 4) 0 (0) (0, 4) 
MRSP = Methicillin-resistant Staphylococcus pseudintermedius; AMD = Antimicrobial drug, CI = Confidence interval 
1
Patients that had MRSP infection within the12 months prior to enrollment 
2
Patients that had surgery or penetrating wound within the 12 months prior to enrollment 
3
Patients that received antimicrobial treatment within 12 months prior to enrollment 
4
Patients that received antimicrobial treatment between sampling times 
